Globe Life (NYSE:GL – Get Free Report) is anticipated to release its Q3 2025 results after the market closes on Wednesday, October 22nd. Analysts expect Globe Life to post earnings of $4.52 per share and revenue of $1.5192 billion for the quarter. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS.Interested persons may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, October 23, 2025 at 11:00 AM ET.
Globe Life (NYSE:GL – Get Free Report) last released its earnings results on Wednesday, July 23rd. The company reported $3.27 earnings per share for the quarter, topping the consensus estimate of $3.25 by $0.02. Globe Life had a return on equity of 21.24% and a net margin of 18.11%.The firm had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same period in the prior year, the business posted $2.97 earnings per share. The firm’s revenue for the quarter was up 2.9% compared to the same quarter last year. On average, analysts expect Globe Life to post $14 EPS for the current fiscal year and $15 EPS for the next fiscal year.
Globe Life Stock Performance
NYSE GL opened at $134.78 on Monday. The business’s 50-day moving average price is $139.85 and its 200 day moving average price is $128.96. Globe Life has a twelve month low of $100.27 and a twelve month high of $147.83. The company has a market capitalization of $10.92 billion, a PE ratio of 10.77 and a beta of 0.55. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.43.
Globe Life Announces Dividend
Insider Buying and Selling
In other Globe Life news, EVP Michael Clay Majors sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $137.41, for a total transaction of $1,374,100.00. Following the completion of the sale, the executive vice president owned 47,066 shares in the company, valued at $6,467,339.06. This trade represents a 17.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Frank M. Svoboda sold 12,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $141.38, for a total value of $1,767,250.00. Following the sale, the chief executive officer owned 32,747 shares of the company’s stock, valued at approximately $4,629,770.86. This trade represents a 27.63% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 84,722 shares of company stock worth $11,733,793 in the last ninety days. 1.97% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Globe Life
A number of hedge funds have recently bought and sold shares of GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Globe Life by 6.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock valued at $1,237,000 after purchasing an additional 607 shares in the last quarter. NewEdge Advisors LLC grew its stake in Globe Life by 368.1% during the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after purchasing an additional 5,352 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Globe Life by 11.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after purchasing an additional 58,163 shares in the last quarter. Empowered Funds LLC acquired a new stake in Globe Life during the 1st quarter valued at approximately $428,000. Finally, Focus Partners Wealth grew its stake in Globe Life by 8.3% during the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after purchasing an additional 656 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on the company. Cfra Research upgraded Globe Life to a “moderate buy” rating in a research note on Friday, July 25th. Wells Fargo & Company upped their price target on Globe Life from $150.00 to $172.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. BMO Capital Markets restated a “market perform” rating and set a $149.00 price target (up from $114.00) on shares of Globe Life in a research note on Wednesday, July 30th. Weiss Ratings restated a “buy (b-)” rating on shares of Globe Life in a research note on Wednesday, October 8th. Finally, Keefe, Bruyette & Woods upped their price target on Globe Life from $145.00 to $155.00 and gave the stock an “outperform” rating in a research note on Monday, July 28th. Eight equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, Globe Life has a consensus rating of “Moderate Buy” and a consensus price target of $152.11.
View Our Latest Analysis on GL
Globe Life Company Profile
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Featured Stories
- Five stocks we like better than Globe Life
- What Are Growth Stocks and Investing in Them
- JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?
- Stock Market Upgrades: What Are They?
- Snap-on Incorporated: Snap It Up Quick, New Highs Will Come Soon
- Stock Market Sectors: What Are They and How Many Are There?
- As Global Renewables Surpass Coal, This ETF Offers Smart Exposure
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.